The need for a network to establish and validate predictive biomarkers in cancer immunotherapy

The need for a network to establish and validate predictive biomarkers in cancer immunotherapy

Abstract Immunotherapies have emerged as one of the most promising approaches to treat patients with cancer. Recently, the entire medical oncology field has been revolutionized by the introduction of immune checkpoints inhibitors. Despite success in a variety of malignancies, responses typically onl...

Full description

Bibliographic Details
Main Authors: Giuseppe V. Masucci, Alessandra Cesano, Alexander Eggermont, Bernard A. Fox, Ena Wang, Francesco M. Marincola, Gennaro Ciliberto, Kevin Dobbin, Igor Puzanov, Janis Taube, Jennifer Wargo, Lisa H. Butterfield, Lisa Villabona, Magdalena Thurin, Michael A. Postow, Paul M. Sondel, Sandra Demaria, Sanjiv Agarwala, Paolo A. Ascierto
Format: Article
Language:English
Published: BMC 2017-11-01
Series:Journal of Translational Medicine
Online Access:http://link.springer.com/article/10.1186/s12967-017-1325-2

Internet

http://link.springer.com/article/10.1186/s12967-017-1325-2

Similar Items